Ju Fu Tang Biotech Holdings Co., Ltd. submitted its Monthly Return to the Hong Kong Stock Exchange for the period ended 31 May 2026, disclosing that the company’s share structure remained unchanged during the month.

Authorised Capital • Authorised share capital stayed at 500.00 million ordinary shares with a par value of HKD 0.16, representing total authorised capital of HKD 80.00 million.

Issued Shares and Treasury Position • Issued shares stood unchanged at 301.86 million. • The company held no treasury shares at month-end, and there were no share repurchases or cancellations.

Public Float • Management confirmed compliance with the 25 % minimum public-float requirement under GEM Rule 17.37D(1).

Share Option Schemes • Scheme granted 12 Jul 2021 (expiry 11 Jul 2026, exercise price HKD 0.315): 10.70 million options outstanding. • Scheme granted 18 Mar 2022 (expiry 17 Mar 2027, exercise price HKD 0.163): 9.14 million options outstanding. • Aggregate outstanding options total 19.84 million shares, equivalent to roughly 6.57 % of current issued share capital. • No options were exercised in May; therefore, no new shares were issued and no funds were raised.

Other Equity Instruments • The filing reported no warrants, convertible securities, Hong Kong Depositary Receipts, or other agreements that could lead to additional share issuance.

Overall, Ju Fu Tang Biotech maintained a stable capital base in May 2026, with future dilution potential limited to the 19.84 million options currently outstanding.